Has Jean Jacques Nya Ngatchou, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,714 in general payments to Jean Jacques Nya Ngatchou, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jean Jacques Nya Ngatchou, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jean Jacques Nya Ngatchou, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jean Jacques Nya Ngatchou, MD

Endocrinology, Diabetes & Metabolism · Everett, WANPI 1396076139

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.0%), food and beverage and education — rather than concentrated in one kind of arrangement. Corcept Therapeutics accounts for 68.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $1,016 and has fallen 78.6% since, to $217 in 2025.

$1,714in general payments, 2019–2025

Across 12 payments — averaging $142.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corcept Therapeutics$1K
Medtronic$147
Tandem Diabetes Care, Inc.$124
Abbott$100
Xeris Pharmaceuticals, Inc.$86
Pharmacosmos Therapeutics Inc.$52
plus $30 from 1 others

$18,431in research payments, 2019–2025

Across 11 payments — averaging $1675.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Corcept Therapeutics$18K

What the payments were for

Speaking & faculty fees$87551%
Food & beverage$73943%
Education$1006%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corcept Therapeutics	6	$1,176
Medtronic	1	$147
Tandem Diabetes Care, Inc.	1	$124
Abbott	1	$100
Xeris Pharmaceuticals, Inc.	1	$86
Pharmacosmos Therapeutics Inc.	1	$52
Sequel Med Tech, LLC	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Korlym$875
MINIMED 780G$147
t:slim X2 Insulin Pump with Control-IQ$124

How this compares

$1,714 in reported general payments places this provider in the 60th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.

See all endocrinology, diabetes & metabolism providers in Washington →

Medicare billing

Part B allowed, 2024

$181,391

Medicare patients

388

Services billed

6,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	154	$208,095
OzempicSemaglutide	107	$189,464
MounjaroTirzepatide	117	$181,635
TrulicityDulaglutide	79	$143,375
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog	34	$62,120
Teriparatide	19	$55,882
Tresiba Flextouch U-200Insulin Degludec	16	$46,400
Tresiba Flextouch U-100Insulin Degludec	41	$45,529
Humalog Kwikpen U-100Insulin Lispro	58	$37,076
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	172	$35,750
FarxigaDapagliflozin Propanediol	18	$28,089
GenotropinSomatropin	11	$27,275
Novolog FlexpenInsulin Aspart	60	$18,705
Cinacalcet Hcl	27	$14,064
Insulin Lispro Kwikpen U-100Insulin Lispro	26	$14,036

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Everett

Isha ShresthaEverett$7K
Shadi BadriehEverett$3K
Sarena ToellnerEverett$2K
Michael ShannonLacey$698K
Lynn KohlmeierSpokane$518K
Carol WyshamSpokane$512K
Bruce WilsonRichland$352K
Irl HirschSeattle$192K
Biju KunhiramanYakima$118K
Nicole EhrhardtSeattle$111K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →